Last reviewed · How we verify
Ze 117
At a glance
| Generic name | Ze 117 |
|---|---|
| Also known as | St. John's wort dry extract Ze 117 |
| Sponsor | Max Zeller Soehne AG |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Drug Cocktail Interaction Study of St. John's Wort Dry Extract Ze 117 (PHASE1)
- Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ze 117 CI brief — competitive landscape report
- Ze 117 updates RSS · CI watch RSS
- Max Zeller Soehne AG portfolio CI